POTENT FGFR4-TARGETED ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR TREATING CANCERS EXPRESSING FGFR4
Technology
E-045-2024
Patent ID
E-045-2024-0-PC-01
Country
PCT
Application Type
PCT
Patent Status
Pending
Patent Number
Publication Number
WO 2025/212999
Application Number
PCT/US2025/023122
IC
NCI
Date Filed
Date Issued
Patent PDF